Misuse of Drugs Act 1973 (Amendment of First Schedule) Order 2023

Status:

Published in Subsidiary Legislation Supplement
on 30 Jun 2023

No. S 453

Misuse of Drugs Act 1973

Misuse of Drugs Act 1973
(Amendment of First Schedule)
Order 2023

In exercise of the powers conferred by section 59 of the Misuse of Drugs Act 1973, the Minister for Home Affairs makes the following Order:

Citation and commencement

1. This Order is the Misuse of Drugs Act 1973 (Amendment of First Schedule) Order 2023 and comes into operation on 1 July 2023.

Amendment of First Schedule

2. In the Misuse of Drugs Act 1973, in the First Schedule —

(a)

in Part 1, in paragraph 16, in item (c), after “alkyl”, insert “, cycloalkyl”;

(b)

in Part 1, in paragraph 16, after item (1), insert —

“(1AAA)

1-(1,3-Benzodioxol-5-yl)-2-(cyclohexylamino)propan-1-one (also known as 3,4-methylenedioxy-N-cyclohexylcathinone or 3,4-methylenedioxy-α-cyclohexylaminopropiophenone or N-cyclohexylmethylone or Cyputylone)”;

(c)

in Part 1, in paragraph 16, after item (1A), insert —

“(1BA)

1-(1,3-Benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (also known as N,N-dimethylpentylone, dipentylone or bk-DMBDP)”;

(d)

in Part 1, in paragraph 16, after item (17), insert —

“(17AA)

4-Methyl-1-phenyl-2-(pyrrolidin-1-yl)pentan-1-one (also known as α-PiHP or α-pyrrolidinoisohexanophenone)”;

(e)

in Part 1, in paragraph 16, after item (20), insert —

“(20A)

1-(3-Methylphenyl)-2-(methylamino)propan-1-one (also known as 3-methylmethcathinone, metaphedrone or 3-MMC)”;

(f)

in Part 1, in paragraph 17, in item (c), after “alkyl”, insert “, cycloalkyl”;

(g)

in Part 1, in paragraph 18, in item (1A), before “bromo positional isomers”, insert “N-(1-amino-1-oxohexan-2-yl) isomers and their respective”;

(h)

in Part 1, in paragraph 18, after item (16A), insert —

“(16B)

2-(2-(4-Butoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine (also known as butonitazene or butoxynitazene) and its diethylamino and butoxy structural isomers and their respective butoxy positional isomers in the phenyl ring and nitro positional isomers in the 6-membered ring of the benzimidazole structure”;

(i)

in Part 1, in paragraph 18, after item (22), insert —

“(22A)

5-(Cyclobutylmethyl)-2-(2-phenylpropan-2-yl)-pyrido[4,3-b]indol-1-one (also known as Cumyl-CB-MeGACLONE, Cumyl-CBMGACLONE, cumyl-cyclobutylmethyl-gammacarbolinone or SGT-273) and its phenylpropyl isomers”;

(j)

in Part 1, in paragraph 18, after item (23), insert —

“(23AA)

N-Cyclohexyl-2-(1-(4-hydroxypentyl)-1H-indol-3-yl)acetamide and its hydroxy positional isomers in the pentyl group

(23AB)

N-Cyclohexyl-2-(1-pentyl-1H-indol-3-yl)acetamide (also known as CH-PIATA)”;

(k)

in Part 1, in paragraph 18, after item (30A), insert —

“(30B)

N,N-Diethyl-2-(2-(4-propoxybenzyl)-5-nitro-1H-benzo[d]imidazol-1-yl)ethan-1-amine (also known as protonitazene or propoxynitazene) and its diethylamino structural isomers and their respective propoxy positional isomers in the phenyl ring and nitro positional isomers in the 6-membered ring of the benzimidazole structure”;

(l)

in Part 1, in paragraph 18, after item (43), insert —

“(43AA)

2-(2-(4-Ethoxybenzyl)-1H-benzo[d]imidazol-1-yl)-N,N-diethylethan-1-amine (also known as etodesnitazene, etazene, etazen, etazone or desnitroetonitazene) and its diethylamino structural isomers and their respective ethoxy positional isomers in the phenyl ring

(43AB)

2-(4-Ethoxybenzyl)-5-nitro-1-(2-pyrrolidin-1-ylethyl)-1H-benzimidazole (also known as etonitazepyne or N-pyrrolidino etonitazene) and its ethoxy positional isomers in the phenyl ring and their respective nitro positional isomers in the 6-membered ring of the benzimidazole structure”;

(m)

in Part 1, in paragraph 18, after item (51A), insert —

“(51B)

N’-(1-Hexyl-2-oxoindolin-3-ylidene)-4-hydroxybenzohydrazide and its hydroxy positional isomers in the phenyl ring”;

(n)

in Part 1, in paragraph 18, after item (54), insert —

“(54AA)

N’-(1-(4-Hydroxycyclohexylmethyl)-2-oxoindolin-3-ylidene)benzohydrazide and its hydroxy positional isomers in the cyclohexyl group”;

(o)

in Part 1, in paragraph 18, after item (70), insert —

“(70A)

1-(2-Methyl-4-(3-phenyl-prop-2-en-1-yl)-piperazin-1-yl)-1-butanone (also known as 2-methyl-AP-237 or 2-methyl buccinazine) and its methyl positional isomers in the piperazinyl ring”;

(p)

in Part 4, in the definition of “cannabinol derivatives”, after “or its tetrahydro derivatives”, insert “and any compound structurally derived from such derivatives by substitution of any of the hydrogen atoms”;

(q)

in Part 4, in the definition of “type A substituent”, replace paragraph (k) with —

“(k)	an arylalkyl group; or”; and

(r)

in Part 4, in the definition of “type B substituent”, replace paragraph (f) with —

“(f)	an arylalkyl group;”.

Made on 27 June 2023.

PANG KIN KEONG

Permanent Secretary,
Ministry of Home Affairs,
Singapore.

[MHA 112/2/49 VOL 1; AG/LEGIS/SL/185/2020/6 Vol. 1]

Search within Legislation